Physician
Rheumatology
Dr. William J. Shergy, MD
Dr. William J. Shergy practices Rheumatology. He studied medicine at Drexel University College of Medicine. He received awards:"Fellow (FACR)" and "Fellow". William Shergy is a published MD. He published 23 publications, including: 'Polymyositis after propylthiouracil treatment for hyperthyroidism.' Doctor William J. Shergy, MD is registered with Medicare.
Publications
- Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid Arthritis and poor prognosis.
- Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid Arthritis: results from...
- Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid Arthritis.
- Infliximab in the treatment of recalcitrant idiopathic orbital inflammation.
- A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid a...
- Costimulatory blockade in patients with rheumatoid Arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eig...
- Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid Arthritis.
- Polymyositis after propylthiouracil treatment for hyperthyroidism.
- Differential diagnosis of pulmonary nodule.
- The relationship of anticardiolipin antibodies to Disease manifestations in pediatric systemic lupus erythematosus.
- Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid Arthritis.
- Acute gouty Arthritis and intravenous nitroglycerin.
- Patterns of autoantibody expression in pediatric and adult systemic lupus erythematosus.
- Silicone synovitis: clinical, radiologic, and histologic features.
- Dysphagia due to diffuse idiopathic skeletal hyperostosis.
- Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early r...
- Longterm reduction of back Pain risk in women with osteoporosis treated with teriparatide compared with alendronate.
- Treatment of rheumatoid Arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controll...
- Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid Arthritis patients.
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid Arthritis receiving concurrent glucocorticoids or bisphosphonates.
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid Arthritis and poor prognostic factors.
- Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid Arthritis and poor prognostic factors treated wit...
Schools
Hahnemann University
Duke University Med Center
University Pa Health Sys Presby M C
Procedures Preformed
- Joint Drainage
- Steroid Injection
- Trigger Point Injection
- Viscosupplementation With Hyaluronate
Conditions Treated
- Adhesive Capsulitis
- Amyloidosis
- Ankylosing Spondylitis
- Arthritis
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Dental Blue 100/200/300
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Golden Rule
- GEHA
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- POMCO Group
- Principal Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
Education
-
Duke University Hospital
-
University of Pennsylvania
-
Drexel University College of Medicine
Drug Facts
| NPI NUMBER |
|
1073531307 |
| NPPES Provider LastName |
|
SHERGY |
| NPPES Provider FirstName |
|
WILLIAM |
| NPPES Provider ZIPCode |
|
358014414 |
| NPPES Provider State |
|
AL |
| Specialty Description |
|
Rheumatology |
| Total Claim Count |
|
8211.0 |
| Distinct Opioid Count |
|
3.0 |
| Opioid Claim Count |
|
703.0 |
| Percent Opioid Claims |
|
8.56 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1073531307 |
| Last Name Of The Provider |
SHERGY |
| First Name Of The Provider |
WILLIAM |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.